142 related articles for article (PubMed ID: 16792528)
1. The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate and activator of the c-Fes protein tyrosine kinase.
Delfino FJ; Shaffer JM; Smithgall TE
Biochem J; 2006 Oct; 399(1):141-50. PubMed ID: 16792528
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions.
Peng H; Begg GE; Schultz DC; Friedman JR; Jensen DE; Speicher DW; Rauscher FJ
J Mol Biol; 2000 Feb; 295(5):1139-62. PubMed ID: 10653693
[TBL] [Abstract][Full Text] [Related]
3. Regulation of c-Fes tyrosine kinase activity by coiled-coil and SH2 domains: analysis with Saccharomyces cerevisiae.
Takashima Y; Delfino FJ; Engen JR; Superti-Furga G; Smithgall TE
Biochemistry; 2003 Apr; 42(12):3567-74. PubMed ID: 12653561
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
[TBL] [Abstract][Full Text] [Related]
5. The structurally disordered KRAB repression domain is incorporated into a protease resistant core upon binding to KAP-1-RBCC domain.
Peng H; Gibson LC; Capili AD; Borden KL; Osborne MJ; Harper SL; Speicher DW; Zhao K; Marmorstein R; Rock TA; Rauscher FJ
J Mol Biol; 2007 Jul; 370(2):269-89. PubMed ID: 17512541
[TBL] [Abstract][Full Text] [Related]
6. A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.
Delfino FJ; Stevenson H; Smithgall TE
J Biol Chem; 2006 Mar; 281(13):8829-35. PubMed ID: 16455651
[TBL] [Abstract][Full Text] [Related]
7. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
Rogers JA; Cheng HY; Smithgall TE
Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
[TBL] [Abstract][Full Text] [Related]
8. The human c-Fes tyrosine kinase binds tubulin and microtubules through separate domains and promotes microtubule assembly.
Laurent CE; Delfino FJ; Cheng HY; Smithgall TE
Mol Cell Biol; 2004 Nov; 24(21):9351-8. PubMed ID: 15485904
[TBL] [Abstract][Full Text] [Related]
9. Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.
Cheng H; Rogers JA; Dunham NA; Smithgall TE
Mol Cell Biol; 1999 Dec; 19(12):8335-43. PubMed ID: 10567558
[TBL] [Abstract][Full Text] [Related]
10. A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.
Cheng HY; Schiavone AP; Smithgall TE
Mol Cell Biol; 2001 Sep; 21(18):6170-80. PubMed ID: 11509660
[TBL] [Abstract][Full Text] [Related]
11. Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells.
Shaffer JM; Hellwig S; Smithgall TE
Biochemistry; 2009 Jun; 48(22):4780-8. PubMed ID: 19382747
[TBL] [Abstract][Full Text] [Related]
12. Oligomerization of the Fes tyrosine kinase. Evidence for a coiled-coil domain in the unique N-terminal region.
Read RD; Lionberger JM; Smithgall TE
J Biol Chem; 1997 Jul; 272(29):18498-503. PubMed ID: 9218495
[TBL] [Abstract][Full Text] [Related]
13. Hetero-oligomerization among the TIF family of RBCC/TRIM domain-containing nuclear cofactors: a potential mechanism for regulating the switch between coactivation and corepression.
Peng H; Feldman I; Rauscher FJ
J Mol Biol; 2002 Jul; 320(3):629-44. PubMed ID: 12096914
[TBL] [Abstract][Full Text] [Related]
14. Expression, purification and preliminary crystallographic studies on the catalytic region of the nonreceptor tyrosine kinase Fes.
Gnemmi I; Scotti C; Cappelletti D; Canonico PL; Condorelli F; Rosano C
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jan; 63(Pt 1):18-20. PubMed ID: 17183165
[TBL] [Abstract][Full Text] [Related]
15. Biochemical analysis of the Kruppel-associated box (KRAB) transcriptional repression domain.
Peng H; Begg GE; Harper SL; Friedman JR; Speicher DW; Rauscher FJ
J Biol Chem; 2000 Jun; 275(24):18000-10. PubMed ID: 10748030
[TBL] [Abstract][Full Text] [Related]
16. Co-expression with BCR induces activation of the FES tyrosine kinase and phosphorylation of specific N-terminal BCR tyrosine residues.
Li J; Smithgall TE
J Biol Chem; 1996 Dec; 271(51):32930-6. PubMed ID: 8955135
[TBL] [Abstract][Full Text] [Related]
17. Contributions of F-BAR and SH2 domains of Fes protein tyrosine kinase for coupling to the FcepsilonRI pathway in mast cells.
McPherson VA; Everingham S; Karisch R; Smith JA; Udell CM; Zheng J; Jia Z; Craig AW
Mol Cell Biol; 2009 Jan; 29(2):389-401. PubMed ID: 19001085
[TBL] [Abstract][Full Text] [Related]
18. KAP-1, a novel corepressor for the highly conserved KRAB repression domain.
Friedman JR; Fredericks WJ; Jensen DE; Speicher DW; Huang XP; Neilson EG; Rauscher FJ
Genes Dev; 1996 Aug; 10(16):2067-78. PubMed ID: 8769649
[TBL] [Abstract][Full Text] [Related]
19. A common DNA-binding site for SZF1 and the BRCA1-associated zinc finger protein, ZBRK1.
Peng H; Zheng L; Lee WH; Rux JJ; Rauscher FJ
Cancer Res; 2002 Jul; 62(13):3773-81. PubMed ID: 12097288
[TBL] [Abstract][Full Text] [Related]
20. HSH2: a novel SH2 domain-containing adapter protein involved in tyrosine kinase signaling in hematopoietic cells.
Oda T; Muramatsu MA; Isogai T; Masuho Y; Asano S; Yamashita T
Biochem Biophys Res Commun; 2001 Nov; 288(5):1078-86. PubMed ID: 11700021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
